Vanitha N. Sivalingam

Author

Also Known As

V N Sivalingam, V Sivalingam, V. Sivalingam, V.N. Sivalingam, VN Sivalingam, Vanitha N Sivalingam, Vanitha N. Sivalingam, Vanitha Sivalingam

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Manchester St Mary's Hospital Manchester Academic Health Science Centre Manchester University NHS Foundation Trust St Mary's Hospital

About

Vanitha N. Sivalingam is an author at University of Manchester specializing in obstetrics, obesity, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	38
2	Obstetrics	2	2	38
3	Obesity	2	2	38
4	Gynecology Oncology	1	1	14
5	Women's Health	1	1	14

Vanitha N. Sivalingam

Publications

904

Citations

H-Index

Page 1

	Year	Citations
Diagnosis and management of ectopic pregnancy Vanitha N. Sivalingam, W. Colin Duncan, E. Kirk, Journal of Family Planning and Reproductive Health Care	2011	323
The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study Neil Ryan, R F McMahon, Simon Tobi, PLoS Medicine	2020	94
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies Sarah Kitson, Vanitha N. Sivalingam, James M. Bolton, Modern Pathology	2016	86
Measuring the biological effect of presurgical metformin treatment in endometrial cancer Vanitha N. Sivalingam, Sarah Kitson, Rhona J. McVey, British Journal of Cancer	2016	82
PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial Sarah Kitson, Zoe Maskell, Vanitha N. Sivalingam, Clinical Cancer Research	2018	61
The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study Sarah Kitson, Jennifer Lindsay, Vanitha N. Sivalingam, Gynecologic Oncology	2017	52
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer Ayşe Latif, Amy L. Chadwick, Sarah Kitson, BMC Clinical Pathology	2017	47
Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study Maria Paraskevaidi, Camilo L. M. Morais, Katherine M. Ashton, Cancers	2020	45
Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin Vanitha N. Sivalingam, Ayşe Latif, Sarah Kitson, British Journal of Cancer	2019	32
Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer Kelechi Njoku, A. Campbell, Bethany Geary, Cancers	2021	31

Page 1